ESRA Academy. Hadzic A. Sep 3, 2015; 113145 Topic: Peripheral Nerve Blocks
Disclosure(s): Dr. Hadzic has consulted and advised for Skypharma, GE, Sonosite, Codman & Shrutleff, Inc (Johnson and Johnson), Cadence, Pacira Pharmaceuticals, Baxter and BBraun Medical. Research funding: Glaxo Smith-Kline Industries, Pacira, Baxter. Dr. Hadzic receives royalty income from BBraun Medical. Ownership interest PCRx and Apple
Mr. Admir Hadzic
Mr. Admir Hadzic

Access to Premium content is currently a membership benefit.

Click here to join ESRA or renew your membership.

Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:
- Recognize the benefits and limitations of single shot interscalene brachial plexus block
- Discuss the role of longer lasting LA
- Explain the pros and cons of perineural catheters
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies